Literature DB >> 28167280

The miR-599 promotes non-small cell lung cancer cell invasion via SATB2.

Wenjun Tian1, Guanghai Wang2, Yiqing Liu1, Zhenglan Huang3, Caiqing Zhang2, Kang Ning2, Cuixiang Yu2, Yajuan Shen1, Minghui Wang1, Yuantang Li1, Yong Wang1, Bingchang Zhang1, Yaoran Zhao1.   

Abstract

MicroRNAs (miRNAs) play important roles in the pathogenesis of many types of cancers by negatively regulating gene expression at posttranscriptional level. Here, we identified that miR-599 is up-regulated in non-small cell lung cancer (NSCLC) patients. It promoted NSCLC cell proliferation by negatively regulating SATB2. In NSCLC cell lines, CCK-8 proliferation assay indicated that the cell proliferation is promoted by miR-599 mimics. Transwell assay showed that miR-599 mimics promoted the invasion and migration of NSCLC cells. Luciferase assays confirmed that miR-599 directly binds to the 3'untranslated region of SATB2, and western blotting showed that miR-599 suppresses the expression of SATB2 at the protein level. This study indicates that miR-599 promotes proliferation and invasion of NSCLC cell lines via SATB2. The miR-599 may represent a potential therapeutic target for NSCLC treatment.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  NSCLC; SATB2; miR-599

Mesh:

Substances:

Year:  2017        PMID: 28167280     DOI: 10.1016/j.bbrc.2017.02.005

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Overexpression of LIMD2 promotes the progression of non-small cell lung cancer.

Authors:  Feifei Zhang; Shana Qin; Xiang Xiao; Yuefa Tan; Peng Hao; Yikai Xu
Journal:  Oncol Lett       Date:  2019-06-12       Impact factor: 2.967

2.  High serum miR-484 expression is associated with the diagnosis and prognosis of patients with non-small cell lung cancer.

Authors:  Zhenli Zhuang; Cuiling Sun; Haitao Gong
Journal:  Exp Ther Med       Date:  2019-09-17       Impact factor: 2.447

3.  MiR-421 inhibits the malignant phenotype in glioma by directly targeting MEF2D.

Authors:  Liang Liu; Sitong Cui; Rui Zhang; Yan Shi; Liangsheng Luo
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

4.  MicroRNA-599 suppresses glioma progression by targeting RAB27B.

Authors:  Yu Jiang; Xiaohui Wang; Ji Zhang; Renchun Lai
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

5.  Long non‑coding RNA HCG11 suppresses the malignant phenotype of non‑small cell lung cancer cells by targeting a miR‑875/SATB2 axis.

Authors:  Zhou Su; Mi Chen; Ruilin Ding; Lian Shui; Qingmei Zhao; Wenjuan Luo
Journal:  Mol Med Rep       Date:  2021-06-03       Impact factor: 2.952

6.  eNOS expression and NO release during hypoxia is inhibited by miR-200b in human endothelial cells.

Authors:  Anna Janaszak-Jasiecka; Anna Siekierzycka; Sylwia Bartoszewska; Marcin Serocki; Lawrence W Dobrucki; James F Collawn; Leszek Kalinowski; Rafal Bartoszewski
Journal:  Angiogenesis       Date:  2018-05-08       Impact factor: 9.596

Review 7.  Oncogenic and tumor suppressive roles of special AT-rich sequence-binding protein.

Authors:  Qiao Yi Chen; Max Costa
Journal:  J Carcinog       Date:  2018-04-05

8.  MiR-599 Protects Cardiomyocytes against Oxidative Stress-Induced Pyroptosis.

Authors:  Xiaoying Fan; Enbo Zhan; Yuan Yao; Ruoxi Zhang; Yong Sun; Xuefeng Tian
Journal:  Biomed Res Int       Date:  2021-02-18       Impact factor: 3.411

9.  Circ_0008035 contributes to cell proliferation and inhibits apoptosis and ferroptosis in gastric cancer via miR-599/EIF4A1 axis.

Authors:  Chang Li; Yuan Tian; Yun Liang; Qingchun Li
Journal:  Cancer Cell Int       Date:  2020-03-16       Impact factor: 5.722

10.  Knockdown of lncRNA NEAT1 suppresses hypoxia-induced migration, invasion and glycolysis in anaplastic thyroid carcinoma cells through regulation of miR-206 and miR-599.

Authors:  Xiangrong Tan; Peng Wang; Jianlin Lou; Jiazheng Zhao
Journal:  Cancer Cell Int       Date:  2020-04-23       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.